scanX
Home
NGL Fine Chem

NGL Fine Chem

1,995.25
-24.15
(-1.20%)
Market Cap (₹ Cr.)
₹1,246
52 Week High
2,823.90
Book Value
₹425
52 Week Low
1,728.10
PE Ratio
29.62
PB Ratio
4.74
PE for Sector
42.31
PB for Sector
22.11
ROE
15.73 %
ROCE
20.73 %
Dividend Yield
0.09 %
EPS
₹68.05
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
24.40 %
Net Income Growth
101.58 %
Cash Flow Change
-41.99 %
ROE
70.82 %
ROCE
70.02 %
EBITDA Margin (Avg.)
35.95 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
25
25
23
23
26
26
22
26
27
22
30
31
33
37
41
35
45
42
38
39
36
45
71
76
74
81
83
86
80
67
69
73
76
73
83
89
100
94
Expenses
20
19
18
18
20
18
17
19
21
19
23
24
26
30
32
27
33
32
33
34
33
30
49
51
51
53
62
69
68
63
60
62
62
62
66
74
83
82
EBITDA
5
5
5
5
7
7
5
7
6
3
7
7
7
7
9
8
12
10
6
5
3
15
22
25
23
28
21
16
12
3
9
10
13
11
17
15
17
13
Operating Profit %
20 %
20 %
21 %
20 %
24 %
24 %
19 %
25 %
19 %
9 %
21 %
18 %
18 %
15 %
18 %
21 %
25 %
21 %
13 %
10 %
6 %
30 %
27 %
30 %
29 %
30 %
21 %
15 %
13 %
0 %
7 %
11 %
16 %
11 %
17 %
13 %
13 %
7 %
Depreciation
1
1
1
1
1
1
1
1
1
1
2
1
1
2
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Interest
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
0
1
1
1
1
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
Profit Before Tax
4
4
4
4
5
6
5
6
5
2
5
6
4
5
7
6
10
8
3
3
1
12
19
23
21
26
19
14
10
1
7
8
11
9
15
13
14
10
Tax
2
2
2
1
2
2
2
2
2
1
1
1
1
2
2
1
3
2
1
1
1
3
4
5
7
6
4
4
3
1
2
2
3
1
3
4
3
2
Net Profit
3
3
3
3
3
4
3
4
3
2
3
4
3
5
4
4
7
6
3
2
0
9
15
18
14
19
14
11
8
1
5
6
9
8
11
9
11
8
EPS in ₹
4.73
4.49
4.14
4.49
5.46
6.68
4.74
6.84
5.59
2.59
5.54
6.87
4.97
7.80
7.15
6.59
11.02
8.97
4.81
3.28
0.23
14.36
23.95
28.35
23.16
31.32
22.97
17.56
12.72
0.83
8.03
9.86
13.81
12.63
17.76
14.40
17.56
12.67
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
67
78
102
129
142
156
206
278
288
353
Fixed Assets
17
24
25
56
61
61
58
59
59
60
Current Assets
44
50
51
56
79
83
123
170
159
204
Capital Work in Progress
1
2
16
3
0
0
1
6
26
46
Investments
2
3
6
6
9
14
33
32
43
57
Other Assets
46
49
55
63
73
80
115
180
159
190
Total Liabilities
34
33
43
57
50
54
50
71
63
90
Current Liabilities
31
32
30
40
38
43
39
63
57
84
Non Current Liabilities
3
2
13
17
12
12
11
8
6
6
Total Equity
33
44
59
72
92
101
155
207
226
263
Reserve & Surplus
30
41
56
69
89
98
152
203
222
260
Share Capital
3
3
3
3
3
3
3
3
3
3
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
0
-0
1
-1
-0
2
-1
7
-7
Investing Activities
-3
-10
-10
-21
-10
-19
-24
-13
-24
-17
Operating Activities
8
8
10
22
9
20
27
13
32
11
Financing Activities
-4
2
0
0
0
-1
-1
-1
-1
-1
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
May 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
73.81 %
73.81 %
73.81 %
73.81 %
73.81 %
73.81 %
73.81 %
73.81 %
73.81 %
73.53 %
73.53 %
73.06 %
73.06 %
72.74 %
72.74 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.05 %
0.05 %
0.05 %
0.00 %
0.00 %
0.00 %
0.02 %
0.04 %
0.10 %
0.03 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.19 %
26.19 %
26.19 %
26.19 %
26.18 %
26.14 %
26.14 %
26.14 %
26.19 %
26.47 %
26.46 %
26.92 %
26.90 %
27.16 %
27.23 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Sun Pharmaceutical
1,919.95 4,62,183.91 43.83 49,887.17 12.06 9,648 42.62 69.11
Divis Laboratories
5,423.80 1,44,579.50 86.37 8,184.00 0.89 1,600 20.79 63.50
Cipla
1,664.85 1,33,571.58 30.05 26,520.66 14.17 4,155 17.77 58.51
Dr Reddys Laboratories
6,749.10 1,12,773.77 20.26 28,905.40 12.36 5,578 -0.90 52.91
Zydus Life Science
1,080.35 1,07,501.01 25.79 19,831.50 13.82 3,831 30.78 42.63
Mankind Pharma
2,578.95 1,01,024.42 51.48 10,615.63 19.57 1,942 9.89 57.29
Lupin
2,194.40 99,904.51 44.14 20,141.50 19.94 1,936 77.69 52.16
Aurobindo Pharma
1,438.30 85,599.77 23.86 29,559.25 17.55 3,169 61.17 35.32
Alkem Laboratories
6,151.25 72,467.15 33.71 12,978.42 9.84 1,811 91.18 54.09
Glenmark Pharmaceuticals
1,666.95 47,227.01 - 12,653.09 6.58 -1,831 96.52 50.20

Corporate Action

Technical Indicators

RSI(14)
Neutral
31.93
ATR(14)
Volatile
84.34
STOCH(9,6)
Oversold
18.49
STOCH RSI(14)
Oversold
0.07
MACD(12,26)
Bearish
-2.10
ADX(14)
Weak Trend
14.46
UO(9)
Bearish
33.97
ROC(12)
Downtrend And Accelerating
-6.13
WillR(14)
Oversold
-86.10
Bearish
3
Neutral
4
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Technical Screeners
Fundamental Screeners
Candlestick Screeners
Intraday Screeners
Price & Volume Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.